Valsartan 137862-53-4 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-01-27
Product Details
- Product NameValsartan
- CAS No.137862-53-4
- EINECS No.604-045-2
- MFC24H29N5O3
- MW435.52
- Appearancepowderwhite to tan
- Melting point 116-117°C
- storage temp. 2-8°C
- Boiling point 684.9±65.0 °C(Predicted)
- density 1.212±0.06 g/cm3(Predicted)
- Water Solubility 84.99mg/L(25 ºC)
Company Profile Introduction
Over 26000 people impacting lives across 4 continents
Zydus group is headquartered in Ahmedabad, India, and ranks 4th in the Indian pharmaceutical industry. The group has manufacturing sites and research facilities spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim in India and in the US and Brazil.
Zydus’ global business has a strong presence in the regulated markets of the US, Europe (France and Spain) and in the high profile markets of Latin America and South Africa. It is also present in a big way in 25 other emerging markets worldwide.
Supplier other products
Recommended supplier
-
VIP1年
- SLS Pharmaceuticals Private Limited
- Valsartan 98%
- Inquiry
- 2024-03-13
-
VIP1年
- Apicore Pharmaceuticals Pvt Ltd
- 137862-53-4 98%
- Inquiry
- 2024-03-07
-
VIP1年
- Mylan Laboratories Ltd
- 137862-53-4 Valsartan 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Optimus Pharma Pvt Ltd (Sekhmet Pharmaventures))
- Valsartan 98%
- Inquiry
- 2024-02-28
-
VIP1年
- BDR Pharmaceuticals International Pvt Ltd
- 137862-53-4 98%
- Inquiry
- 2024-02-24
-
VIP1年
- Biophore India Pharmaceuticals Pvt Ltd
- 137862-53-4 Valsartan 98%
- Inquiry
- 2024-02-21
-
VIP1年
- Alfa Omega Pharma
- Valsartan 137862-53-4 98%
- Inquiry
- 2024-02-17
-
VIP1年
- Ralington Pharma
- Valsartan 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Raising Sun Pharma
- 137862-53-4 98%
- Inquiry
- 2024-02-03
-
VIP1年
- Amara Labs Pvt Ltd
- 137862-53-4 Valsartan 98%
- Inquiry
- 2024-01-29
- Since:2024-01-01
- Address: Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Near Vaishnodevi Circle,
INQUIRY